Ilya Zubkov
Stock Analyst at Freedom Capital Markets
(2.98)
# 2,657
Out of 4,486 analysts
20
Total ratings
62.5%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Ilya Zubkov
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAGE Niagen Bioscience | Initiated Coverage: Buy | $9 | $3.49 | +157.88% | 1 | Jul 6, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Initiated Coverage: Buy | $27 | $7.53 | +258.57% | 1 | Jul 2, 2026 | |
| SMTI Sanara MedTech | Initiated Coverage: Buy | $35 | $24.70 | +41.70% | 1 | Jun 17, 2026 | |
| ATYR aTyr Pharma | Upgraded: Buy | $3.5 | $0.6247 | +460.27% | 1 | May 20, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $46.20 | - | 1 | May 20, 2026 | |
| ATRA Atara Biotherapeutics | Upgraded: Hold | $10 | $10.38 | -3.66% | 1 | May 18, 2026 | |
| AMGN Amgen | Upgraded: Buy | $375 | $369.05 | +1.61% | 1 | May 7, 2026 | |
| BIIB Biogen | Upgraded: Buy | $245 | $206.75 | +18.50% | 1 | May 1, 2026 | |
| INGN Inogen | Initiated Coverage: Buy | $12 | $6.55 | +83.21% | 1 | Apr 7, 2026 | |
| ANGO AngioDynamics | Initiated Coverage: Buy | $16 | $13.05 | +22.61% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1.5 | $0.3671 | +308.61% | 1 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $116 | $99.36 | +16.75% | 1 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $4.77 | +319.29% | 1 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.09 | +187.08% | 1 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $37 | $19.76 | +87.25% | 2 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $5.58 | +97.13% | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $9.83 | +32.25% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $45.40 | n/a | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $4.90 | n/a | 1 | Mar 18, 2025 |
Niagen Bioscience
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $3.49
Upside: +157.88%
Arcturus Therapeutics Holdings
Jul 2, 2026
Initiated Coverage: Buy
Price Target: $27
Current: $7.53
Upside: +258.57%
Sanara MedTech
Jun 17, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $24.70
Upside: +41.70%
aTyr Pharma
May 20, 2026
Upgraded: Buy
Price Target: $3.5
Current: $0.6247
Upside: +460.27%
Sionna Therapeutics
May 20, 2026
Downgraded: Hold
Price Target: n/a
Current: $46.20
Upside: -
Atara Biotherapeutics
May 18, 2026
Upgraded: Hold
Price Target: $10
Current: $10.38
Upside: -3.66%
Amgen
May 7, 2026
Upgraded: Buy
Price Target: $375
Current: $369.05
Upside: +1.61%
Biogen
May 1, 2026
Upgraded: Buy
Price Target: $245
Current: $206.75
Upside: +18.50%
Inogen
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $6.55
Upside: +83.21%
AngioDynamics
Apr 6, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $13.05
Upside: +22.61%
Apr 6, 2026
Downgraded: Hold
Price Target: $1.5
Current: $0.3671
Upside: +308.61%
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $116
Current: $99.36
Upside: +16.75%
Mar 30, 2026
Upgraded: Buy
Price Target: $20
Current: $4.77
Upside: +319.29%
Sep 30, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $2.09
Upside: +187.08%
Aug 11, 2025
Upgraded: Buy
Price Target: $14 → $37
Current: $19.76
Upside: +87.25%
Aug 4, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $5.58
Upside: +97.13%
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $13
Current: $9.83
Upside: +32.25%
Jul 1, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $45.40
Upside: n/a
Mar 18, 2025
Maintained: Buy
Price Target: $13
Current: $4.90
Upside: n/a